Table II -.
Outcomes in at-risk participants (current and former smokers) with lung cancer
| EarlyCDT-Lung test result | ||||||||
|---|---|---|---|---|---|---|---|---|
| Test-positive | Test-negative | Not tested | Total | |||||
| *Event within 28 days of a Covid test. | ||||||||
| **Odds ratio (Test-positive vs Test-negative). | ||||||||
| Stage | N | % | N | % | N | % | N | % |
| Stage 3 | 0 | (0.0) | 1 | (14.3) | 4 | (44.4) | 5 | (27.8) |
| Stage 4 | 0 | (0.0) | 1 | (14.3) | 0 | (0.0) | 1 | (5.6) |
| Other | 2 | (0.0) | 5 | (71.4) | 5 | (55.6) | 12 | (66.7) |
| Total | 2 | (100) | 7 | (100) | 9 | (100) | 18 | (100) |
| Covid result | N | % | N | % | N | % | N | % |
| Test-positive | 0 | (0.0) | 1 | (14.3) | 1 | (11.1) | 2 | (11.1) |
| Test-negative | 2 | (100.0) | 6 | (85.7) | 8 | (88.9) | 16 | (88.9) |
| Total | 2 | (100) | 7 | (100) | 9 | (100) | 18 | (100) |
| OR** = 0.00 (0.00, 66.5) p = 1.0 | ||||||||
| Hospitalized* | N | % | N | % | N | % | N | % |
| No | 0 | (0.0) | 4 | (57.1) | 3 | (33.3) | 7 | (38.9) |
| Yes | 2 | (100.0) | 3 | (42.9) | 6 | (66.7) | 11 | (61.1) |
| Total | 2 | (100) | 7 | (100) | 9 | (100) | 18 | (100) |
| OR** = 0.00 (0.00, 4.20) p = 0.44 | ||||||||
| Death* | N | % | N | % | N | % | N | % |
| No | 2 | (100.0) | 6 | (85.7) | 9 | (100.0) | 17 | (94.4) |
| Yes | 0 | (0.0) | 1 | (14.3) | 0 | (0.0) | 1 | (5.6) |
| Total | 2 | (100) | 7 | (100) | 9 | (100) | 18 | (100) |
| OR** = 9999 (0.015, 9999) p = 1.0 | ||||||||